← Back to Search

Behavioral Intervention

REJOICE for Depression in Rural African Americans (REJOICE Trial)

N/A
Waitlist Available
Led By Tiffany F Haynes, PhD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately upon completion of 8 week intervention
Awards & highlights

REJOICE Trial Summary

This trialwill test a new intervention to help reduce depression in rural African American communities. It will also collect data to ensure successful implementation.

Eligible Conditions
  • Depression

REJOICE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately upon completion of 8 week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately upon completion of 8 week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mental Depression

REJOICE Trial Design

2Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Churches in the REJOICE intervention arm will provide the REJOICE intervention over an 8 week period
Group II: ControlExperimental Treatment1 Intervention
Churches in the control arm will receive an educational materials about both identifying depressive symptoms and managing depressive symptoms. This is consistent with self-management interventions commonly utilized for individuals experiencing subclinical levels of depressive symptoms.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
REJOICE
2016
N/A
~190

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,169 Total Patients Enrolled
6 Trials studying Depression
909 Patients Enrolled for Depression
Tiffany F Haynes, PhDPrincipal InvestigatorAssistant Professor
1 Previous Clinical Trials
600 Total Patients Enrolled
Karen Yeary, PhDPrincipal InvestigatorAssociate Professor
1 Previous Clinical Trials
425 Total Patients Enrolled

Media Library

REJOICE (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02860741 — N/A
Depression Clinical Trial 2023: REJOICE Highlights & Side Effects. Trial Name: NCT02860741 — N/A
Depression Research Study Groups: Intervention, Control

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently taking part in this research endeavor?

"Affirmative. The clinicaltrials.gov website states that the trial is actively enrolling subjects, with a post date of May 1st 2016 and an edit on October 17th 2022. Specifically, 360 patients are needed between 2 medical centres."

Answered by AI

Are there current openings to join this experiment?

"Affirmative. Clinicaltrials.gov confirms that this medical trial, first posted on May 1st 2016, is still recruiting participants from 2 centres around the world; 360 in total are needed for completion of the study."

Answered by AI

Who else is applying?

What state do they live in?
Arkansas
How old are they?
18 - 65
What site did they apply to?
Second Baptist Church of England
What portion of applicants met pre-screening criteria?
Met criteria
~21 spots leftby Apr 2025